Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Enterprise value to sales ratio
5Y CAGR
+30.5%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 214.22 | - |
| 2024 | 0.00 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 4.37 | -92.3% |
| 2020 | 56.59 | +1015.1% |
| 2019 | 5.07 | +35.8% |
| 2018 | 3.74 | -68.7% |
| 2017 | 11.93 | -25.9% |
| 2016 | 16.11 | - |